still losing weight after stopping semaglutide Two Years GLP-1s, Most Patients Sustain at Least Some Loss How to Not Gain Weight

GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis

During this phase, you may notice mild appetite suppression and reduced hunger cravings

According to FDA prescribing information, approximately 6% of patients receiving Zepbound discontinued treatment due to adverse reactions compared to 2-3% receiving placebo, with gastrointestinal events being the most common reasons for discontinuation

Rapid metabolic changesparticularly in the first 24 weeks of treatmentmay trigger perceived chills even as objective body temperature remains normal

While panic attacks are not a standard side effect, some people may experience physical symptoms like a racing heart or nausea that can trigger a panic response